Company Insider Tape

Jasper Therapeutics Inc insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol JSPR Latest filing 20 Jul 2026

Company Read

Acquisition-led

JSPR has 3 stored insider filings. Acquisitions account for 100.0% of classified filings and disposals account for 0.0%.

Latest filing 20 Jul 2026most recent stored row
Largest filing $0reported transaction value
Total filings 3stored transaction rows
Acquisition value $03 acquisitions
Disposal value $00 disposals
Net value $0acquisitions minus disposals

Filing cadence

Last 12 active months
Jul 2026 3

Acquisitions 100.0% · Disposals 0.0%

Jul 2026 $0

Executive concentration

By filing count
CRUTCHER, PATRICK J Director · 2 filings
ROS, MATTHEW E Chief Operating Officer · 1 filings

Market Context

JSPR weekly market snapshot

Week 31 Jul 2026
Latest close 0.63 USDstored weekly close
1-week move -8.5%latest weekly bar
13-week move +47.1%medium-term context
Relative Strength -62.8Sharemaestro indicator
Fair value gap -93.5%price vs fair value
Trend signal 0smoothed trend state

Transaction History

Latest insider filings for JSPR

Showing 1-3 of 3
Date 20 Jul 2026
Insider CRUTCHER, PATRICK JDirector
Side Acquisition
Shares 888
Price -
Value -
Security Non-Voting Convertible Preferred Stock
Date 20 Jul 2026
Insider ROS, MATTHEW EChief Operating Officer
Side Acquisition
Shares 881
Price -
Value -
Security Non-Voting Convertible Preferred Stock
Date 16 Jul 2026
Insider CRUTCHER, PATRICK JDirector
Side Acquisition
Shares 15000
Price 0.00
Value 0
Security Stock Option (Right to Buy